<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) October 16, 2000
----------------
BIOZHEM COSMECEUTICALS, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Texas
----------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-14725 76-0118305
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
32238 Paseo Adelanto Suite A San Juan Capistrano, CA. 92675
--------------------------------------------------------------------------------
(Address of Principal Executive Officers) (Zip Code)
(949) 488-2184
----------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
---------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Reported)
Item 5. OTHER EVENTS
------------
On October 16, 2000, Biozhem Cosmeceuticals, Inc. ("Biozhem") completed
net financing of one million dollars ($1,000,000) to be used in the direct
response marketing of skin care products containing the nutrient solution
developed by Advance Tissue Sciences, Inc.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Biozhem Cosmeceuticals, Inc.
October 18, 2000 By: /s/ JOHN C. RIEMANN
---------------- ---------------------------
John C. Riemann, Chairman
